Last year, the American Academy of Ophthalmology recommended that patients experiencing vision problems while taking semaglutide stop using the drug and consult a physician.
A unique collaboration between electrical engineers and ophthalmologists solves clinical, computational challenges.
A new study breaks down several cases of Ozempic blindness, linked to semaglutide and tirzepatide. Here's what could be behind this.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback